Professor Linqi Zhangâ€™s laboratory has uncovered the structure of SARS-CoV-2 spike receptor-binding domain binding with cell receptor angiotensin converting enzyme 2, and isolated more than 200 receptor-binding domain-specific monoclonal antibodies against SARS-CoV-2. The top SARS-CoV-2 neutralizing antibodies are now under development with partnership in pharmaceutical industry.